Analyzing Vivani Medical (NASDAQ:VANI) & Gadsden Properties (OTCMKTS:GADS)

Gadsden Properties (OTCMKTS:GADS) and Vivani Medical (NASDAQ:VANI) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Earnings & Valuation

This table compares Gadsden Properties and Vivani Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gadsden Properties	N/A	N/A	N/A	N/A	N/A
Vivani Medical	N/A	N/A	-$25.65 million	($0.45)	-2.51

Insider and Institutional Ownership

6.8% of Vivani Medical shares are owned by institutional investors. 5.0% of Gadsden Properties shares are owned by insiders. Comparatively, 44.3% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Gadsden Properties has a beta of -5.57, indicating that its stock price is 657% less volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.22, indicating that its stock price is 222% more volatile than the S&P 500.

Profitability

This table compares Gadsden Properties and Vivani Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Gadsden Properties	N/A	N/A	N/A
Vivani Medical	N/A	-102.42%	-49.21%

Analyst Recommendations

This is a summary of current recommendations and price targets for Gadsden Properties and Vivani Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gadsden Properties	0	0	0	0	0.00
Vivani Medical	0	0	1	0	3.00

Vivani Medical has a consensus price target of $3.00, indicating a potential upside of 165.49%. Given Vivani Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than Gadsden Properties.

Summary

Vivani Medical beats Gadsden Properties on 6 of the 8 factors compared between the two stocks.

About Gadsden Properties

Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.

About Vivani Medical

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.